Stock Screener App
Frei
-
Play Store
App Store
Installieren
Installieren
Dark
DE
Sign in
Beobachtungsliste
Top-Listen
Märkte
Neu
Kryptos
Branchen
Elite
Marktsimulator
COAG
$45.57
1.06%
0.48
Hemab Therapeutics Holdings Inc (COAG)
Indikator
5
EX
1min
5min
Hourly
Daily
Weekly
Monthly
Line
Candle
Überblick
Nachrichten
Preisverlauf
Finanzen
Forum
Prognose
Ähnlich wie COAG
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
In EDGAR öffnen
|
In Reuters öffnen
Finanzdaten der Hemab Therapeutics Holdings Inc-Aktie (COAG)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums
2026-06-30
2026-03-31
Periodenlänge
3 Monate
3 Monate
Operating Expenses
10.45%
26.08
23.61
Selling, General, and Administrative
38.35%
5.74
4.15
Research and Development
4.50%
20.34
19.46
Operating Income/Loss
10.45%
-26.08
-23.61
Income/Loss From Continuing Operations Before Tax
6.08%
-24.05
-22.68
Income Tax Expense/Benefit
708.33%
0.10
0.01
Net Income/Loss
6.45%
-24.15
-22.69
Attributable To Parent
6.45%
-24.15
-22.69
Basic Average Shares
3,083%
30.11
0.95
Diluted Average Shares
3,083%
30.11
0.95
Basic Earnings Per Share
96.66%
-0.80
-23.98
Diluted Earnings Per Share
96.66%
-0.80
-23.98
